ATC Φάρμακα Δραστικές ICPC2 ICD10 Ιατρική στην Πράξη Νοσήματα Λοιμώξεις Εμβόλια Πρωτόκολλα
  • Bromazepam
  • indication:For the short-term treatment of insomnia, short-term treatment of anxiety or panic attacks, if a benzodiazepine is required, and the alleviation of the symptoms of alcohol- and opiate-withdrawal.
  • pharmacologypharmacology:
  • mechanism: Bromazepam binds to the GABA receptor GABA<sub>A</sub>, causing a conformational change and increasing inhibitory effects of GABA. Other neurotransmitters are not influenced.
  • toxicity:
  • absorprion: Bioavailability is 84% following oral administration.
  • halflife: 10-20 hours
  • roouteelimination:
  • volumedistribution:
  • clearance: